# Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients

> **NCT02430298** · PHASE2 · COMPLETED · sponsor: **Khon Kaen University** · enrollment: 39 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Matched Placebo

## Key facts

- **NCT ID:** NCT02430298
- **Lead sponsor:** Khon Kaen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2016-02-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02430298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02430298, "Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02430298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*